Thyroid Cancer Prevalent Among Transgender Female Veterans
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 29, 2023 -- There is a high prevalence of thyroid cancer among transgender female veterans, according to a study presented at the annual meeting of the American Thyroid Association, held from Sept. 27 to Oct. 1 in Washington, D.C.
John Christensen, M.D., from the University of California Davis, and colleagues examined the prevalence of thyroid cancer in transgender female veterans (January 2017 to January 2022). The authors reviewed individual charts to identify trends in clinical presentation.
The researchers found that the prevalence of thyroid cancer among transgender female veterans was 0.341 percent, with 29 patients having papillary, seven having follicular, and thee having Hürthle cell carcinoma. At the time of diagnosis, the average age was 53.8 years. Nearly three in 10 patients (29.4 percent) had extrathyroidal disease at diagnosis. Of the 11 participants receiving estrogen gender-affirming hormone therapy at diagnosis, treatment began an average of 6.85 years before diagnosis.
"About one-third of our patients had been receiving estrogen for an average of over five years before diagnosis, which suggests estrogen gender-affirming hormone therapy is a potentially important risk factor," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Lesbian, Bisexual Women Face Premature Death Versus Heterosexual Women
TUESDAY, May 7, 2024 -- Female nurses identifying as lesbian or bisexual have markedly earlier mortality than heterosexual nurses, according to a study published online April 25...
GLP1 Receptor Agonist Use Does Not Seem to Increase Risk for Thyroid Cancer
WEDNESDAY, April 24, 2024 -- Glucagon-like peptide 1 (GLP1) receptor agonist use does not appear to be associated with an increased risk for thyroid cancer, according to a study...
Evidence Lacking for Gender Dysphoria Treatments for Teens
FRIDAY, April 12, 2024 -- Evidence is lacking for use of puberty blockers and hormone treatment for gender dysphoria/incongruence, according to two systematic reviews published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.